These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 34738755

  • 1. [Maternal-fetal cytomegalovirus infection : experience in Liege and new antenatal screening and care strategy].
    Zaffuto K, Capelle X, De Gottal E, Van Linthout C.
    Rev Med Liege; 2021 Nov; 76(11):811-816. PubMed ID: 34738755
    [Abstract] [Full Text] [Related]

  • 2. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy.
    Yinon Y, Farine D, Yudin MH.
    Obstet Gynecol Surv; 2010 Nov; 65(11):736-43. PubMed ID: 21375790
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus infection during pregnancy: state of the science.
    Leruez-Ville M, Foulon I, Pass R, Ville Y.
    Am J Obstet Gynecol; 2020 Sep; 223(3):330-349. PubMed ID: 32105678
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
    Seidel V, Hackelöer M, Rancourt RC, Henrich W, Siedentopf JP.
    Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
    [Abstract] [Full Text] [Related]

  • 9. Universal first-trimester cytomegalovirus screening and valaciclovir prophylaxis in pregnant persons: a cost-effectiveness analysis.
    Fisher SA, Miller ES, Yee LM, Grobman WA, Premkumar A.
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100676. PubMed ID: 35714861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection.
    Codaccioni C, Vauloup-Fellous C, Letamendia E, Saada J, Benachi A, Vivanti AJ.
    J Gynecol Obstet Hum Reprod; 2019 Apr; 48(4):287-289. PubMed ID: 30634004
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging.
    Lipitz S, Yinon Y, Malinger G, Yagel S, Levit L, Hoffman C, Rantzer R, Weisz B.
    Ultrasound Obstet Gynecol; 2013 May; 41(5):508-14. PubMed ID: 23288698
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antenatal treatment options for primary cytomegalovirus infections.
    Kagan KO, Sonek J, Hamprecht K.
    Curr Opin Obstet Gynecol; 2018 Dec; 30(6):355-360. PubMed ID: 30169462
    [Abstract] [Full Text] [Related]

  • 20. A 2-year study on cytomegalovirus infection during pregnancy in a French hospital.
    Picone O, Vauloup-Fellous C, Cordier AG, Parent Du Châtelet I, Senat MV, Frydman R, Grangeot-Keros L.
    BJOG; 2009 May; 116(6):818-23. PubMed ID: 19432571
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.